Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Lifevantage Market Cap 2010-2025 | LFVN

Lifevantage market cap history and chart from 2010 to 2025. Market capitalization (or market value) is the most commonly used method of measuring the size of a publicly traded company and is calculated by multiplying the current stock price by the number of shares outstanding. Lifevantage market cap as of June 20, 2025 is $0.16B.
  
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $0.158B $0.200B
Lifevantage Corporation is a health and nutrition company. The company is the maker of Protandim(R), the Nrf2 Synergizer(R) patented dietary supplement, the TrueScience(TM) Anti-Aging Skin Care Regimen, Canine Health and the AXIO(TM) energy product line. Lifevantage Corporation is headquartered in Salt Lake City, Utah.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $90.196B 21.78
Becton Dickinson (BDX) United States $48.270B 11.95
Cardinal Health (CAH) United States $39.000B 20.42
Straumann Holding AG (SAUHY) Switzerland $19.980B 0.00
West Pharmaceutical Services (WST) United States $15.506B 32.50
Cooper (COO) United States $13.893B 17.90
Align Technology (ALGN) United States $13.177B 26.16
Henry Schein (HSIC) United States $8.761B 15.03
Merit Medical Systems (MMSI) United States $5.436B 26.28
DENTSPLY SIRONA (XRAY) United States $3.061B 9.14
CONMED (CNMD) United States $1.615B 12.08
STAAR Surgical (STAA) United States $0.809B 0.00
Pro-Dex (PDEX) United States $0.132B 14.48